Step 1 topics → Respiratory → NSCLC — Large Cell Carcinoma

NSCLC — Large Cell Carcinoma

USMLE Step 1 trap: Expects specific positive markers for large cell carcinoma rather than recognizing it as a diagnosis of exclusion. Large cell carcinoma is a diagnosis of exclusion — it lacks the glandular, squamous, or neuroendocrine differentiation markers of other subtypes and is diagnosed when none of those patterns are present.

Large cell carcinoma is the least common NSCLC subtype and is tested on USMLE Step 1 primarily as a diagnosis of exclusion — the mistake students make is expecting a positive confirmatory marker, which doesn't exist for this tumor. It's a poorly differentiated peripheral lung tumor with no glandular features, no squamous differentiation, and no neuroendocrine markers. When IHC is negative for TTF-1, p40, synaptophysin, and chromogranin and the cells are large and pleomorphic, large cell carcinoma is what remains.

Where students get tripped up is assuming that every cancer diagnosis requires a specific positive marker to confirm it. That's true for adenocarcinoma (mucin, TTF-1) and squamous cell carcinoma (keratin pearls, p40). Large cell carcinoma breaks that pattern — it's defined by what it lacks, not what it has. USMLE Step 1 exploits this by describing a lung tumor with large pleomorphic cells, negative IHC across the board, and asking what the diagnosis is. Students who search for a positive 'large cell marker' will be thrown off.

Prognosis is poor and similar to other NSCLC subtypes — worse than small cell in some staging scenarios but still managed with surgery when localized. The key clinical fact: it tends to be peripheral (like adenocarcinoma) and presents late. Keep this one brief in your studying — know it's a diagnosis of exclusion, know it's poorly differentiated, and move on.

From real student decks
73%have cards covering this topic
51%have mature cards

Common misconceptions

Common mistake
Wrong: Large cell carcinoma has specific positive histologic markers that confirm the diagnosis.
Right: Large cell carcinoma is a diagnosis of exclusion — it lacks the glandular, squamous, or neuroendocrine differentiation markers of other subtypes and is diagnosed when none of those patterns are present.
Large cell carcinoma has no specific positive immunohistochemical markers that confirm it — that's the whole point. Other lung tumors are defined by what they express: TTF-1 for adenocarcinoma, p40/p63 for squamous cell, synaptophysin/chromogranin for neuroendocrine tumors. Large cell carcinoma is what you call it when none of those markers are present and the cells are too undifferentiated to assign to another category. If you're looking for a positive confirmatory stain for large cell, you're asking the wrong question — the diagnosis comes from ruling everything else out.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the defining features of large cell carcinoma — large pleomorphic cells with no squamous, glandular, or neuroendocrine differentiation — and understand that its prognosis is poor, similar to other NSCLC subtypes.

Can you avoid these mistakes?

A peripheral lung mass is biopsied and shows large pleomorphic cells with abundant cytoplasm. Immunohistochemistry is negative for TTF-1, p40, synaptophysin, and chromogranin. What is the most likely diagnosis, and what principle does this case illustrate?
A 60-year-old smoker has a 3 cm peripheral lung mass. Biopsy shows undifferentiated cells with no glandular or squamous features. The pathologist orders TTF-1, p40, and synaptophysin — all negative. The ordering physician asks whether more IHC stains would help confirm the diagnosis. What would you tell them, and what is the correct diagnosis?
A 65-year-old with a peripheral lung mass is found to have large cell carcinoma. His surgeon is considering resection. How does large cell carcinoma's prognosis compare to adenocarcinoma and squamous cell carcinoma at the same stage, and what does this mean for his surgical candidacy?
On a USMLE Step 1 practice exam, you see a lung mass described as peripheral with large pleomorphic cells and no differentiation markers on IHC. You're deciding between adenocarcinoma and large cell carcinoma. What single finding would clinch adenocarcinoma over large cell, and what does its absence tell you?

Related topics

Lung Cancer Overview and Screening Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →